3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
44
Triple Negative Breast Neoplasms
20
Breast Neoplasms
16
Carcinoma, Non-Small-Cell Lung
14
Neoplasm Metastasis
10
Lung Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
8
Parkinson Disease 4, Autosomal Dominant Lewy Body
7
Neoplasms
6
Adenocarcinoma
6
Cholangiocarcinoma
5
Stomach Neoplasms
4
Gallbladder Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Esophageal Neoplasms
4
Biliary Tract Neoplasms
4
Uterine Cervical Neoplasms
3
Recurrence
3
Pancreatic Adenocarcinoma
3
Ovarian Neoplasms
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Endometrial Neoplasms
3
Colorectal Neoplasms
3
Small Cell Lung Carcinoma
2
Sarcoma
2
Rectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Pancreatic Ductal
2
Carcinoma, Hepatocellular
2
Interventions
fludarabine
19
Whole-Body Irradiation
18
Cyclophosphamide
17
fludarabine phosphate
16
ruxolitinib
15
Mycophenolic Acid
14
Specimen Handling
13
Tacrolimus
11
Azacitidine
11
Biopsy
10
Peripheral Blood Stem Cell Transplantation
9
Melphalan
9
Cytarabine
9
venetoclax
8
Sirolimus
8
Busulfan
8
Stem Cell Transplantation
6
Injections
6
Granulocyte Colony-Stimulating Factor
6
Daunorubicin
5
Cyclosporine
5
CPX-351
5
luspatercept
4
ivosidenib
4
itacitinib
4
fedratinib
4
decitabine and cedazuridine drug combination
4
Thiotepa
4
Liposomes
4
Cyclosporins
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Albumin-Bound Paclitaxel
×
1 year
×
Clear all
No trials found.